These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 3595441)

  • 21. Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias.
    Allen JD; Kelly JG; James RG; Shanks RG; Zaidi SA
    Postgrad Med J; 1977; 53 Suppl 1():35-47. PubMed ID: 876952
    [No Abstract]   [Full Text] [Related]  

  • 22. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological research on bonnecor and its metabolites].
    Poppe H; Heer S; Barch R
    Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
    Sakai K; Yamazaki T; Takagi M
    Tohoku J Exp Med; 1987 Apr; 151(4):443-51. PubMed ID: 3617055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of 6,7-dimethoxycoumarin on experimental arrhythmia].
    Du GY; Ye WH; Lü F; Jing HD
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S16-8. PubMed ID: 8010065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 32. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
    Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
    Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic actions of a new coronary vasodilator agent, iproveratril.
    Hanna C; Schmid JR
    J Ark Med Soc; 1967 May; 63(12):455. PubMed ID: 4227477
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-arrhythmic activity of quaternary derivatives of trimecaine in experimental ventricular arrhythmias].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP
    Biull Eksp Biol Med; 1982 Nov; 94(11):55-7. PubMed ID: 7150740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.